Franchise risk is low; monetization risk is medium. The main threats are export-control expansion, supplier or
qualification slippage during the 2027-2028 capacity ramp, and a semiconductor
capex digestion that delays
backlog conversion. Even if revenue compounds well, investors still face the possibility that a
premium multiple compresses as the company gets larger.